首页> 外文期刊>The American journal of drug and alcohol abuse >Detection of carfentanil in a cluster of patients without associated mortality: Response to Chhabra et al.
【24h】

Detection of carfentanil in a cluster of patients without associated mortality: Response to Chhabra et al.

机译:在一组无相关死亡率的患者中检测卡芬太尼:对 Chhabra 等人的反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

An analysis of fentanyl analog exposures in Cook County, Illinois recently published in this journal by Chhabra et al. found that more than half of urine drug screens detected at least one fentanyl analog or synthetic opioid (1). The relative ease of manufacturing and cost-cutting measures in the illicit drug industry has caused a flooding of the market with synthetic opioids, which is reflected in reported overdose deaths, as synthetic opioid-involved deaths increased 1040 from 2013 to 2019 (2). Use and overdose of carfentanil specifically has increased rapidly around the United States since it was first identified in patient samples in 2016 (3). Given the high potency of the drug (approximately 10,000 times as potent as morphine), most cases of carfentanil use have been identified postmortem, which poses a serious threat to patients with opioid use disorder.
机译:Chhabra等人最近发表在该杂志上的伊利诺伊州库克县芬太尼类似物暴露分析发现,超过一半的尿液药物筛查检测到至少一种芬太尼类似物或合成阿片类药物(1)。非法药物行业的制造相对容易和成本削减措施导致合成阿片类药物市场泛滥,这反映在报告的过量死亡中,因为从 2013 年到 2019 年,涉及合成阿片类药物的死亡人数增加了 1040%(2)。自 2016 年首次在患者样本中发现卡芬太尼以来,卡芬太尼的使用和过量在美国各地迅速增加 (3)。鉴于该药物的高效性(约为吗啡的 10,000 倍),大多数卡芬太尼使用病例已在死后被发现,这对阿片类药物使用障碍患者构成严重威胁。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号